HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Help viewing high resolution images Return to article

FIGURE 2. Comparison of decline in CLR in 28 patients treated with ⁹⁰Y-DOTATOC (A) and 37 patients treated with ¹⁷⁷Lu-DOTATATE (B). Especially with ¹⁷⁷Lu-DOTATATE, most patients have CLR loss <5%/y (normal age-related CLR loss is 1%/y). Only patients with CLR loss >25%/y are expected to develop ESRD within 5 y.

Return to article